Release Date: 29/06/18 09:34 Summary: Clarification of Twitter post on 24 June 2018 Price Sensitive: Yes Download Document 156.21KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%